What one share of Bio-Techne holds
Bio-Techne and its subsidiaries, collectively doing business as Bio-Techne Corporation (“Bio-Techne”, “we”, “our”, “us” or the “Company”), develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide.
Bio-Techne’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $7.74 |
|---|---|
| Profit | $1.16 |
| Capex (buildings and equipment) | $0.18 |
| Free cash flow | $1.68 |
| Dividends | $0.32 |
| Cash and investments | $1.70 |
| Debt | $1.28 |
| Book value | $13.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $1.74 | $0.69 | $0.04 | $0.69 | $0.19 | $3.02 |
| 2010 | $1.80 | $0.73 | $0.03 | $0.71 | $0.26 | $3.39 |
| 2011 | $1.95 | $0.76 | $0.02 | $0.83 | $0.27 | $3.94 |
| 2012 | $2.13 | $0.76 | $0.04 | $0.82 | $0.28 | $4.58 |
| 2013 | $2.10 | $0.76 | $0.15 | $0.69 | $0.29 | $5.01 |
| 2014 | $2.42 | $0.75 | $0.09 | $0.83 | $0.31 | $5.37 |
| 2015 | $3.04 | $0.72 | $0.13 | $0.80 | $0.32 | $5.70 |
| 2016 | $3.34 | $0.70 | $0.11 | $0.85 | $0.32 | $5.90 |
| 2017 | $3.75 | $0.51 | $0.10 | $0.86 | $0.32 | $6.36 |
| 2018 | $4.22 | $0.83 | $0.14 | $0.98 | $0.32 | $7.17 |
| 2019 | $4.59 | $0.62 | $0.16 | $1.00 | $0.32 | $7.68 |
| 2020 | $4.69 | $1.45 | $0.33 | $0.97 | $0.32 | $8.98 |
| 2021 | $5.75 | $0.87 | $0.27 | $1.90 | $0.32 | $10.03 |
| 2022 | $6.74 | $1.66 | $0.27 | $1.71 | $0.32 | $10.86 |
| 2023 | $7.02 | $1.76 | $0.24 | $1.34 | $0.32 | $12.47 |
| 2024 | $7.21 | $1.05 | $0.39 | $1.47 | $0.32 | $13.08 |
| 2025 | $7.64 | $0.46 | $0.19 | $1.61 | $0.32 | $12.38 |
| 2026 | $7.74 | $1.16 | $0.18 | $1.68 | $0.32 | $13.51 |
Common questions about Bio-Techne
How much does one share of Bio-Techne earn?
Over its latest fiscal year, each share of Bio-Techne earned $1.16 of profit on $7.74 of sales, keeping about 15¢ of every $1 (profit margin).
Does Bio-Techne pay a dividend?
Yes. Bio-Techne paid $0.32 per share in dividends over its latest fiscal year, and it paid a dividend in every year from 2009 to 2026 in StockSlicer’s data. That’s about 28¢ of each $1 of profit (payout ratio).
What is Bio-Techne’s book value per share?
Bio-Techne’s book value is $13.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bio-Techne have?
Each share of Bio-Techne has $1.70 of cash and investments and $1.28 of debt, as of June 30, 2026.
What is Bio-Techne’s free cash flow per share?
$1.68 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
How has Bio-Techne’s profit per share changed over time?
Profit per share went from $0.69 in 2009 to $1.16 in 2026, growing about 3.1% a year (adjusted for stock splits).
Has Bio-Techne bought back shares?
Bio-Techne’s share count rose about 4% from 2009 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.